Acción DRREDDY DR. REDDY'S LABORATORIES LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Dr. Reddy's Laboratories Limited

Acciones

DRREDDY

INE089A01023

Mercado cerrado - Bombay S.E.
Otros sitios de cotización
 12:00:50 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
6.253 INR +0,58 % Gráfico intradía de Dr. Reddy's Laboratories Limited +5,23 % +7,85 %
26/04 La renta variable asiática negociada en EE.UU. como recibos de depósito estadounidenses tiende al alza en la jornada del viernes y termina la semana con una subida del 3,5 MT
25/04 Las acciones tecnológicas lideran las acciones asiáticas negociadas en EE.UU. como recibos de depósito estadounidenses a la baja en la negociación del jueves MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
Banking Stocks Lift Indian Equities Higher
Dr. Reddy's Laboratories Names CEO-North America
Dr. Reddy's Laboratories Limited Announces Executive Changes
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
Dr Reddy Laboratories : Corporate_Governance_Report- March 31_2024
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K
Dr. Reddy's Labortories Launches Care Plan for IBS Patients
India's Biocon developing its own version of Wegovy, clinical trial likely next year
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Dr. Reddy's Laboratories Limited Receives an Order from the Commissioner of CGST,, Chandigarh
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción DRREDDY
  4. Noticias Dr. Reddy's Laboratories Limited
  5. Otros idiomas